Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT07013240
Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact (BotuCiSter)
Immediate Post-surgical Botulinum Toxin Injections to Prevent Dystrophic Scars After Sternotomy : a Placebo-controlled Randomized Clinical Trial
Sponsor: University Hospital, Bordeaux
Conditions
Sternotomy Closure,Open Heart Surgery
Interventions
Botulinum toxin injection
Updated 1 time since 2025 Last updated: Jun 2, 2025 Started: Jul 5, 2025 Primary completion: Feb 28, 2027 Completion: Feb 28, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07013240, this PHASE3 trial focuses on Sternotomy Closure,Open Heart Surgery and remains actively recruiting participants. Sponsored by University Hospital, Bordeaux, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Bordeaux
Data source: University Hospital, Bordeaux
For direct contact, visit the study record on ClinicalTrials.gov .